Clinical Trial Update: Symbicort Onset of Action 1 [Phase 3]

View source ↗

Summary

Completed Phase 3 trial update assessing the onset of action of Symbicort in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED